Welcome to Universal Medical
The Board of Directors

Board Diversity

The Board of Directors of Genertec Universal Medical has adopted a Board Membership Diversity Policy, which outlines the approach to achieve diversity among board members in terms of skills, professional experience, educational background, knowledge, expertise, culture, independence, race, ethnicity, cultural background, age and gender. The Nomination Committee will review the Board Diversity Policy (if applicable) to ensure its effectiveness.


Board Industry Experience

The Board of the Group is responsible for managing and leading the Group’s business and holds full authority in this regard. Our Board consists of 3 Executive Directors, 4 Non-executive Directors and 4 Independent Non-executive Directors. The members of the Board possess extensive and diverse industry experience.


Executive Directors

Mr. Chen Shisu – Chairman of the Board , Executive Director

Mr. Chen Shisu has extensive experience in information technology, healthcare, and corporate governance. Since August 2022, he has served as the Deputy Chief Economist of China General Technology (Group) Holding Co., Ltd., the controlling shareholder of Universal Medical. Since April 2023 and July 2023, he has been the Chairman and Party Secretary of General Technology Group Health Management Technology Co., Ltd., respectively. He also served as the Chairman and Party Secretary of Aerospace Medical Health Technology Group Co., Ltd. (formerly known as Aerospace Medical Health Technology Co., Ltd.) from November 2018 to April 2024 and from October 2020 to July 2023, respectively. Additionally, from June 2012 to November 2018, he held various positions at Aerospace Information Co., Ltd. (a company listed on the Shanghai Stock Exchange, stock code: 600271), including Director of the Asset Operation Department, Deputy General Manager, and Board Secretary. From July 1999 to June 2012, he held several positions at China Aerospace Science and Industry Corporation (now known as China Aerospace Science and Industry Corporation Limited), including Deputy Director of the Planning Division of the Development Planning Department and Director of the Fixed Asset Investment Division of the Development Planning Department.

 Mr. Chen obtained a Bachelor’s degree in Engineering from Chongqing University in July 1995 and a Master’s degree in Management Science and Engineering (part-time) from Harbin Institute of Technology in October 2018.

 

Mr.Wang Wenbing – Executive Director, Chief Executive Officer

Mr. Wang Wenbing has extensive experience in finance, healthcare, and corporate governance. He holds certifications of Senior Accountant, Senior Economist, and Senior International Financial Manager, and he earns a Bachelor’s degree in Accounting and a Master’s degree in Finance from the Central University of Finance and Economics. He currently serves as the Executive Director, General Manager, and Deputy Party Secretary of Genertec Universal Medical Group Co., Ltd., and concurrently as the General Manager of China Universal Leasing Co., Ltd.

Mr. Wang served as the financial director at China National Technical Import and Export Corporation from 1996 to 2006, and at General Technology Group's German and Italian companies. From 2006 to 2012, he held the positions of General Manager of the Accounting Department and General Manager of the Capital Department at the General Technology Group's Financial Management Department. From 2012 to 2016, he was a Director and Deputy General Manager of General Technology Finance Company (also serving as Deputy General Manager of the Financial Management Headquarters of General Technology Group). From 2016 to 2019, he was the Deputy General Manager and Discipline Inspection Secretary of General Universal Medical Group Co., Ltd. From 2019 to 2021, he served as the Party Committee Secretary and General Manager of General Technology Group Finance Company (also holding the position of Director of the Financial Center of General Technology Group since 2020).

 

Ms. Wang Lin – Executive Director

Ms. Wang Lin has extensive experience in the healthcare industry and corporate governance. She served as a director and deputy general manager of General Technology Group Health and Elderly Care Sector Co., Ltd., (“GT-HECS”), a subsidiary of China General Technology (Group) Holding Co., Ltd., (“GT-PRC”) (the controlling shareholder of the Company) from August 2022 to July 2023, and served as the party secretary of GT-HECS from December 2022 to July 2023. From May 2019 to August 2022, she undertook several positions in a subsidiary of GT-PRC covering inspection, testing and certification, from the leader of the business group of inspection, testing and certification, to the director and the general manager. From January 2020 to September 2021, she served as a director of China Automotive Engineering Research Institute Co., Ltd, a company listed on the Shanghai Stock Exchange (stock code: 601965).

Ms. Wang obtained a bachelor’s degree (majored in Government Administration) in July 1999 from Xi’an Political College, where she also received her master’s degree in the same major in February 2006. Ms. Wang was qualified as a senior engineer in December 2018 by the State Administration for Market Regulation of China.

 

Non-executive Directors

Mr. Chan Kai Kong – Non-executive Director

Mr. Chan Kai Kong, has extensive experience in financing and investment. Mr. Chan has been a non-executive director of Frontier Services Group Limited, the shares of which are listed on the Stock Exchange (stock code: 0500), since February 2021. Mr. Chan joined CITIC Capital Holdings Limited in 2005, and he was the chief financial officer and a senior managing director. He was also an investment committee member of various funds of Trustar Capital, the private equity business of CITIC Capital Holdings Limited. Mr. Chan was a vice president of the direct investment department at Government of Singapore Investment Corporation from 2001 to 2005 and an investment professional at International Finance Corporation from 1997 to 2000. He previously worked for Deloitte and had corporate finance experience with both listed companies and merchant bank.

Mr. Chan obtained a master’s degree in finance in 1997 from the London Business School and a bachelor’s degree in business administration in 1991 from The Chinese University of Hong Kong.

 

Mr. Tong Chaoyin – Non-executive Director

Mr. Tong Chaoyin has extensive experience in real estate, healthcare and corporate governance. He served as a general manager assistant and the board secretary of China General Technology (Group) Holding Company Limited (“GT-PRC”) , several positions in China Xinxing Corporation (Group), including general manager, secretary of the Party Committee and chairman of this company. Mr. Tong served as the general manager of China Xinxing Real Property Development Company.

Mr. Tong graduated from Nankai University in July 1986 with a bachelor’s degree in law, and graduated from China University of Political Science and Law in July 1989 with a master’s degree in law. Mr. Tong obtained the certificate of senior economist granted by China Xinxing Corporation (Group) in October 1996, and the qualification of Level-One In-house Legal Counsel granted by GR-PRC in September 2010.

 

Mr. Xu Ming – Non-executive Director

Mr. Xu Ming, has extensive experience in financial sector and corporate governance. Mr. Xu has been the general manager of Genertec Hong Kong International Capital Limited, a subsidiary of the Company’s controlling shareholder, China General Technology (Group) Holding Company Limited (“GT-PRC”), since September 2018. From August 2008 to February 2020, Mr. Xu served as a director of China Meheco Group Co., Ltd., the shares of which are listed on the Shanghai Stock Exchange (stock code: 600056). From July 1998 to September 2018, Mr. Xu successively served as a department manager, a vice general manager and the general manager of the financial management department of GT-PRC.

Mr. Xu received a master’s degree in business administration (part-time) from Tsinghua University in January 2013 and a bachelor’s degree in accounting from Beijing Institute of Business in June 1988. Mr. Xu was qualified as a senior accountant in August 2002 by Appraisal and Approval Committee for Professional & Technical Qualification of GT-PRC.

 

Mr. Zhu Ziyang Non-executive Director

Mr Zhu Ziyang has extensive experience in fields of real estate, healthcare and information technology. Mr. Zhu has been the head for the smart medical sector of Guangdong Yuanzhi Technology Group Co., Ltd. (“Yuanzhi Technology”) since June 2021, primarily responsible for operation and management of its smart medical sector. Mr. Zhu has been the head for the traditional Chinese medicine sector of Yuanzhi Technology since May 2020, primarily responsible for operation and management of its traditional Chinese medicine sector. Prior to that, he served as the assistant to the principal of the strategy committee of Hopson Development Holdings Limited, the shares of which are listed on The Stock Exchange of Hong Kong Limited (stock code: 0754), from July 2017 to May 2020.

Mr. Zhu obtained his bachelor's degree in management from Beijing Institute of Technology in June 2017.

 

Independent Non-executive Directors

Mr. Li Yinquan Independent Non-executive Director

Mr Li Yinquan has extensive experience in financial sector. Mr. Li worked in the Agricultural Bank of China, and served respectively as the General Manager of Financial Department, Chief Financial Officer, Vice President of China Merchants Group and CEO of China Merchants Capital Investment Co., Ltd from 2000 to 2017. Mr. Li also served as an executive director of China Merchants Port Holdings Company Limited (formerly known as China Merchants Holdings (International) Company Limited)HKEx: 144) from June 2001 to March 2015, a non-executive director of China Merchants Bank Co., Ltd. (HKEx: 3968; SSE: 600036) from April 2001 to June 2016, an executive director of China Merchants China Direct Investments Limited (HKEx: 133) from July 2008 to April 2017 and, independent non-executive director of Lizhi Inc. (NASDAQ: LIZI) from January 2020 to June 2021. 

Mr. Li was awarded a Bachelor degree in Economics from Shaanxi Institute of Finance and Economics , China in July 1983. He was then awarded a Master Degree in Economics from Graduate School of the People’s Bank of China (now known as the PBC School of Finance, Tsinghua University) in July 1986. In October 1988, Mr. Li obtained a Master Degree in Banking and Finance for Development from Finafrica in Milan, Italy. In August 1989, he obtained the qualification as a senior economist granted by the Appraisal and Approval Committee for Professional & Technical Qualification of the Agricultural Bank of China.


Mr. Chow Siu Lui Independent Non-executive Director

Mr. Chow Siu Lui is specialized in accounting and finance, and she has a wealth of experience in fund raising and initial public offering activities in Hong Kong. He was the partner of VMS Investment Group (HK) Ltd. from 2012 to April 2023 and he was responsible for providing advice on issues regarding fund raising, pre-IPO group  restructuring and due diligence exercises for investment projects. Prior to that, Mr. Chow was in service  with KPMG Hong Kong for about 28 years and was admitted as one of its partners in 1995. He was then  mainly responsible for initial public offering advisory services and assisting in fund raising activities in local  and overseas stock exchanges.

Mr. Chow was awarded a Professional Diploma in Accountancy from the Hong Kong Polytechnic University (formerly known as Hong Kong Polytechnic), Hong Kong in November 1983. By profession, he became a fellow of the Association of Chartered Certified Accountants in July 1991, the ICSA and HKICS both in October 2009, and the HKICPA in December 1993.

 

Mr. Xu Zhiming Independent Non-executive Director

Mr. Xu Zhiming, has extensive experience in finance, real estate and information technology and corporate governance. Mr. Xu served as (i) an independent non-executive director of Tianjin Capital Environmental Protection Group Company Limited, the shares of which are listed on the Stock Exchange (stock code: 1065) and the Shanghai Stock Exchange (stock code: 600874), and (ii) an independent non-executive director of Orient Securities Co., Ltd, the shares of which are listed on the Stock Exchange (stock code: 3958) and the Shanghai Stock Exchange (stock code: 600958). Mr. Xu currently serves as a director in Donlink Group Co., Ltd., Guangzhou Donlink Industrial Investment Group Co., Ltd., Beijing Lianhang Hezhong Media Technology Co., Ltd. and Beijing Baoxuan Culture Media Co., Ltd. respectively, and is a founding partner of China Broadband Capital. From August 1999 to December 2001, Mr. Xu successively served as an executive director of China Resources Enterprise, Limited, an executive director of China Resources (Beijing) Land Limited, the managing director and chief operating officer of China Resources Logic Limited. From January 2002 to May 2005, Mr. Xu successively served as a senior consultant, an executive director and chief operating officer of TOM Online Inc. 

Mr. Xu received a PhD degree in economics from University of Manchester in the United Kingdom in February 1993, a master’s degree in industrial economy from Chinese Academy of Social Science in July 1986 and a bachelor’s degree in astrophysics from Peking University in July 1983.

 

Mr. Chan, Hiu Fung Nicholas MH, JP Independent Non-executive Director

Mr. Chan, Hiu Fung Nicholas is a practicing lawyer in Hong Kong with over 20 years of legal experience. He has extensive expertise in the public utilities and telecommunications services sectors, and possesses a background in information security management. He has been with Hanyu International Law Firm since April 1999 and became a partner in September 2005. Prior to that, he served as an lawer at Deacons Hongkong. Mr. Chen has extensive experience serving on the boards of listed companies, including: (i) an independent non-executive director of Million Cities Holdings Limited, a company listed on the Stock Exchange (stock code: 2892) since December 2021, (ii) an independent non-executive director of Pangeaea Connectivity Technology Limited , a company listed on the Stock Exchange (stock code: 1473) since January 2021, (iii) an independent non-executive director of Q P Group Holdings Limited, a company listed on the Stock Exchange (stock code:1412), since December 2019, and (iv) an independent non-executive director of Sa Sa International Holdings Limited, a company listed on the Stock Exchange (stock code:0178), since September 2019.

Mr. Chan graduated from the University of Melbourne, Australia, in March 1997 with a degree of bachelor of laws and a degree of bachelor of science. Mr. Chan was admitted as a solicitor in Hong Kong in May 1999. He was also admitted as a solicitor of Australia Capital Territory, the State of Victoria in Australia and England and Wales in June 1997, October 2000 and October 2007, respectively. He was appointed as a China-Appointed Attesting Officer by Ministry of Justice of the People’s Republic of China.


Mr. Chan has been appointed as a Director of the AALCO Hong Kong Regional Arbitration Centre since May 2022 to lead the operations of the Centre. The Centre was established by agreement between the Central People's Government of the People's Republic of China and the Asian-African Legal Consultative Organization (AALCO), an intergovernmental organization established in 1956, which now has 47 member States.

Mr. Chan has been appointed as a member of the Council of The Chinese University of Hong Kong for a term of three years from June 2022 onwards. Mr. Chan has been a member of the Council of the Hong Kong University of Science and Technology from April 2016 to March 2022. He was appointed as a member of the Legal Aid Services Council for a term of two years commencing September 2018 and renewed for another term of two years commencing September 2020. Mr. Chan was also appointed as a member of the Hospital Governing Committee of Castle Peak Hospital and Siu Lam Hospital from April 2019 onwards. Mr. Chan was previously the chairman of BMI Online Arbitration Centre, an independent and non-profit-making company with limited liability by guarantee established under the laws of Hong Kong. Mr. Chan was appointed as a deputy to the 13th National People's Congress of the People's Republic of China in 2019. He was awarded the Medal of Honor by the Government of the Hong Kong Special Administrative Region in July 2016 and appointed as a Justice of the Peace from July 2021 by the Government of the Hong Kong Special Administrative Region.



Establishment of the Commission

The Board has established five committees, namely:

 

the Audit Committee

Mr. Li Yinquan(chairman)

Mr. Chow Siu Lui

Mr. Tong Chaoyin


the Remuneration Committee

Mr. Chow Siu Lui(chairman)

Mr. Chan Kai Kong

Mr. Xu Ming

Mr. Li Yinquan

Mr. Xu Zhiming


the Nomination Committee

Mr. Chen Shisu(chairman)

Mr. Xu Ming

Mr. Li Yinquan

Mr. Chow Siu Lui

Mr. Chan,Hiu Fung Nicholas


the Strategy and ESG Committee

Mr. Chen Shisu(chairman)

Mr. Chan Kai Kong

Mr. Zhu Ziyang

 

the Risk Control Committee

Mr. Zhu Ziyang(chairman)

Mr. Wang Wenbing

Mr. Tong Chaoyin